CareDx, Inc. (CDNA) stock
CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3024% above fair value
$74.56+0.84 (+1.14%)
Close on Nov 17, 2026Market cap $3.92BP/E 31.2Yield –
CareDx pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
CareDx's pe ratio was 39.2× on Nov 11, 2026, against 15.2× a year earlier. Over the last 2 years it ranged from 11.0× to 381.7×, with a median of 24.2×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 39.2× | +25.5 |
| 2025 | Dec 31, 2025 | 13.7× | −95.3 |
| 2015 | Jul 31, 2015 | 109.0× | −272.7 |
| 2014 | Dec 31, 2014 | 381.7× | – |
See a number that looks wrong?